Countries World

Seven AI/ML Life Sciences Innovators in Clarivate's Watchlist

United States and Mainland China continue to lead innovation and remain at the forefront of AI technology advancement for drug discovery  C...

 September 28, 2023 | News

Cytel Expands Market Access and Medical Communication with co.faktor Acquisition

As a result, Cytel’s services for biopharma commercialization will gain new and complementary specialist consultancy capabilities and localized exper...

 September 27, 2023 | News

Cellectricon expands neuroscience contract research portfolio with new Neuroplasticity services

Cellectricon, a services provider dedicated to advancing neuroscience drug discovery,  announced the launch of a new service module for neuroplasticit...

 September 27, 2023 | News

Merck to Become First Provider to Offer Fully Integrated mRNA Services

New sites at Darmstadt and Hamburg complement Merck’s global integrated mRNA service network with pre-clinical to commercial capabilities Company&...

 September 27, 2023 | News

MicuRx Receives FDA QIDP and Fast Track Designation for Contezolid & Acefosamil

The QIDP and Fast Track designations were created as part of the Food and Drug Administration Safety and Innovation Act, FDASIA (June 2012), Titl...

 September 25, 2023 | News

Mabxience and Abbott Forge Strategic Deal to Expand Biosimilars Access in Emerging Markets

Abbott to commercialize several biosimilar molecules in key emerging markets in Latin America, Southeast Asia and Middle East and Africa mAbxience Holdi...

 September 21, 2023 | News

Integrated DNA Technologies and Aldevron Partner to Provide CRISPR Components to Therapy Developers

    Leading CRISPR gene editing companies Integrated DNA Technologies and Aldevron inked a new global distribution agreement to...

 September 19, 2023 | News

Singleron Unveils AccuraCode® TCR Kit for Streamlined T-Cell Profiling

The product is built upon Singleron's molecular barcoding technology, enabling multiplexing of 96 or 384 samples in a single library construction reaction....

 September 14, 2023 | News

Exelixis and Insilico Medicine Ink Global License Deal for ISM3091, a Leading USP1 Inhibitor

— ISM3091 is a highly selective, orally bioavailable small molecule inhibitor of USP1 identified through Insilico Medicine's artificial int...

 September 14, 2023 | News

Waters Introduces Simplified Solutions for Biologic Drug Analysis

  Updated Waters™ OneLab™ software creates new, easy-to-use walk-up solutions integrating Waters BioAccord™ LC-MS system and...

 September 13, 2023 | News

Verily and Kyverna Collaborate to Advance Cell Therapy for Autoimmune Diseases

Verily, an Alphabet precision health technology company, and Kyverna Therapeutics ("Kyverna"), a clinical-stage cell therapy company engineering a new clas...

 September 08, 2023 | News

Paige Partners with Microsoft to Create World's Largest Cancer-Fighting AI Model

Paige, a global leader in end-to-end digital pathology solutions and clinical AI, developed the first Large Foundation Model using over one billion images ...

 September 08, 2023 | News

Diseases we could eradicate | Polio

The chart here highlights the global decline of the estimated number of paralytic polio cases from 1980 onwards. In the peak year 1981, the ...

 September 07, 2023 | Analysis | By by Saloni Dattani, Fiona Spooner, Sophie Ochmann and Max Roser This article was first published in November 2017. It was last updated in April 2022.

Thermo Fisher Speeds Up Cell Therapy Manufacturing with Next-Gen Gibco™ CTS™ Dynabeads™ Platform

Thermo Fisher Scientific Inc., the world leader in serving science, today announced the Gibco CTS Detachable Dynabeads (CTS Detachable Dynabeads)...

 September 07, 2023 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close